Guidance on potential exclusion of certain WFD priority substances from MSFD monitoring beyond coastal and territorial waters
|Ref.||A pragmatic and qualitative approach for the open sea. EUR 30655 EN, , JRC124593. Publications Office of the European Union, Luxembourg, 2021, ISBN 978-92-76-33187-2 (online)|
|Author(s)||Tornero Alvarez Maria Victoria, Hanke Georg, Haber Annabelle, Kuenitzer Anita, Mauffret Aourell, Munch Christensen Anne, Oros Andrea, McHugh Brendan, Maggi Chiara, Bijstra Dju, Ten Hulscher Dorien, McGovern Evin, Vaha Emmi, Giorgi Giordano, Hatzianestis I, Aigars Juris, Bellas Juan, Campillo Juan Antonio, Lusic Jelena, Mannio Jaako, Antoniadis Konstantinos, Kamenova Kalinka, Parmentier Koen, Varenius Kerstin, Van Der Stap Irene, Viñas Lucía, Furdek Turk Martina, Korsjukov Margus, Laht Mailis, Wessel Nathalie, Dimitrova Stefana, Porsbring Tobias, Zalewska T, Kammann Ulrike, Pirntke Ulrike, Coatu Valentina, Leon Victor|
According to Commission Decision (EU) 2017/848 under the Marine Strategy Framework Directive (MSFD), EU Member States (MS) shall consider, in their Descriptor 8 primary criterion (D8C1) assessments, the WFD Priority Substances (PS) and River Basin Specific Pollutants (RBSP) within coastal and territorial waters and also beyond territorial waters if these still may give rise to pollution effects. Some WFD PS might not be relevant for the marine environment in the open sea and, consequently, might be excluded from MSFD monitoring beyond the territorial waters. MS have expressed the need for a framework for the deselection of WFD PS from monitoring under the MSFD, in order to save resources. The European Commission’s Joint Research Centre (JRC), collaborating within the MSFD Expert Network on Contaminants, has developed a pragmatic approach to identify the WFD PS that can be excluded from MSFD monitoring in the open sea beyond territorial waters without reducing protection of European Seas. This should preempt the need for individual MS to provide rationales for such exclusions, support comparable monitoring and assessments across national boundaries, and enable MS to focus their monitoring efforts on other (including emerging) substances that require attention.